Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PLAB | Common Stock | Options Exercise | $3.41K | +300 | +0.08% | $11.35 | 400K | Dec 30, 2021 | Direct | |
transaction | PLAB | Common Stock | Sale | -$5.81K | -300 | -0.08% | $19.36 | 400K | Dec 30, 2021 | Direct | F1, F2, F3 |
transaction | PLAB | Common Stock | Options Exercise | $27.6K | +2.43K | +0.61% | $11.35 | 402K | Dec 30, 2021 | Direct | |
transaction | PLAB | Common Stock | Sale | -$47.1K | -2.43K | -0.61% | $19.35 | 400K | Dec 30, 2021 | Direct | F1, F2, F3 |
transaction | PLAB | Common Stock | Options Exercise | $32.3K | +3.75K | +0.94% | $8.60 | 403K | Jan 3, 2022 | Direct | |
transaction | PLAB | Common Stock | Sale | -$71.2K | -3.75K | -0.93% | $18.98 | 400K | Jan 3, 2022 | Direct | F1, F3 |
transaction | PLAB | Common Stock | Tax liability | -$164K | -8.69K | -2.17% | $18.85 | 391K | Jan 3, 2022 | Direct | F4 |
transaction | PLAB | Common Stock | Tax liability | -$190K | -9.85K | -2.52% | $19.28 | 381K | Jan 3, 2022 | Direct | F5 |
transaction | PLAB | Common Stock | Tax liability | -$186K | -9.85K | -2.58% | $18.85 | 371K | Jan 3, 2022 | Direct | F6 |
transaction | PLAB | Common Stock | Award | $0 | +90K | +24.24% | $0.00 | 461K | Jan 3, 2022 | Direct | F7 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PLAB | Stock Options (Right to Buy) | Options Exercise | $0 | -300 | -4.17% | $0.00 | 6.89K | Dec 30, 2021 | Common Stock | 300 | $11.35 | Direct | |
transaction | PLAB | Non-Qualified Stock Options | Options Exercise | $0 | -2.43K | -11.29% | $0.00 | 19.1K | Dec 30, 2021 | Common Stock | 2.43K | $11.35 | Direct | |
transaction | PLAB | Stock Options (Right to Buy) | Options Exercise | $0 | -3.75K | -100% | $0.00* | 0 | Jan 3, 2022 | Common Stock | 3.75K | $8.60 | Direct |
Id | Content |
---|---|
F1 | The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Dr. Kirlin. |
F2 | This transaction was executed in multiple trades. The price reported above reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and the prices at which the transaction was effected. |
F3 | Net proceeds of sale to offset a tax liability from restricted stock vesting and to fund children's education. |
F4 | Shares withheld to meet tax liabilities associated with Restricted Stock Awards granted on January 2, 2019. |
F5 | Shares withheld to meet tax liabilities associated with Restricted Stock Awards granted on January 3, 2020. |
F6 | Shares withheld to meet tax liabilities associated with Restricted Stock Awards granted on January 2, 2021. |
F7 | 25% of the Restricted Stock Awards granted will vest on each anniversary date of the grant over 4 years. |